Gene amplification is the most frequent genetic alteration in breast cancer with MYC, CCND1, epidermal growth factor receptor (EGFR), fibroblast growth factor receptor (FGFR), CDK4, and MDM2 being the genes most frequently amplified in primary and recurrent breast tumors (3, 5–10). Here, MYC is linked to breast cancer.